Botulinum toxin type A for neuropathic pain in patients with spinal cord injury

OBJECTIVE: To evaluate the analgesic effect of botulinum toxin type A (BTX‐A) on patients with spinal cord injury‐associated neuropathic pain. METHODS: The effect of BTX‐A on 40 patients with spinal cord injury‐associated neuropathic pain was investigated using a randomized, double‐blind, placebo‐co...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Zee‐A, Song, Dae Heon, Oh, Hyun‐Mi, Chung, Myung Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825405/
https://www.ncbi.nlm.nih.gov/pubmed/26814620
http://dx.doi.org/10.1002/ana.24605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825405/
https://www.ncbi.nlm.nih.gov/pubmed/26814620
http://dx.doi.org/10.1002/ana.24605

Ejemplares similares